Kilitch to divest entire stake in Ethiopian subsidiary KEB
Kilitch to divest entire stake in Ethiopian subsidiary KEB — Kilitch Drugs announced the disinvestment of its entire stake in KEB, its Ethiopian subsidiary, via a press release dated October 23, 2026. The move signals a strategic exit from international operations. Financial details of the divestment were not disclosed.
📊 STOCKS: KILITCH | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Divestment
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.